Licensing Partners Identification for client’s proprietary technology based neonatal MSCsOpportunity Assessment through Secondary & Primary Intelligence.
A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from across the globe. They wished to identify a potential list of companies, to become a fit for their neonatal high quality MSCs and can prove to be a good business partner as a licensee for their proprietary “API” of the stem cell therapy domain.
Providing scientific innovation a boost towards clinical development and commercial milestone achievement
Service that helps identify, acquire, measure and manage collaborations